EvolutionaryScale
EvolutionaryScale provides a generative foundation model for biology that enables researchers to program proteins by reasoning across sequence, structure, and function simultaneously.
Excellent for biotech R&D teams performing de novo protein design, but overkill for standard protein folding tasks where AlphaFold suffices.
Analysis based on product data, pricing structure, traffic signals, and public user sentiment.
Who Should Use EvolutionaryScale?
Typical users
Computational biologists, drug discovery researchers, and protein engineers at biotech startups or pharmaceutical enterprises.
Maturity fit
Advanced
Choose this if…
- You need to design novel proteins with specific functional constraints rather than just predicting existing structures.
- Your workflow requires a multimodal approach that integrates sequence, structure, and chemical function.
- You have the computational infrastructure or AWS credits to run large-scale biological foundation models.
Skip this if…
- Your primary goal is simple 3D structure prediction of known sequences (AlphaFold 2 is the industry standard for this).
- You are a bench scientist looking for a no-code GUI; this is a developer-centric API and model suite.
- You lack the budget for high-end GPU compute or enterprise-grade API costs.
About EvolutionaryScale
EvolutionaryScale is a frontier AI research lab founded by the former Meta AI ESM team. It focuses on generative biology, treating biological data as a language to simulate and accelerate the evolution of proteins for therapeutics and industrial applications.
Official profiles
What it actually does
The tool provides access to ESM3, a multimodal foundation model trained on billions of protein sequences and structures. It allows users to prompt the model with partial biological information—such as a specific active site or a desired fold—and generates the remaining protein data to fulfill those requirements.
What makes it different
Unlike AlphaFold, which is primarily a predictive model for structure, ESM3 is natively generative. It can reason across three different biological modalities at once, allowing it to 'write' new biological code that has never existed in nature, as demonstrated by their creation of a novel fluorescent protein.
Key Features
ESM3 Model Suite
Provides a range of model sizes from 1.4B (open) to 98B parameters for varying complexity.
Multimodal Reasoning
Allows users to specify a protein's function and structure to generate the corresponding sequence.
AWS HealthOmics Integration
Simplifies deployment for enterprise teams already using Amazon's cloud infrastructure.
Tokenized Biological Data
Converts complex 3D structures into discrete tokens, making biological design feel like text generation.
Chain-of-Thought Biology
Enables the model to iteratively refine protein designs based on structural constraints.
Open Source Weights
Offers a smaller 1.4B parameter version for local research and experimentation.
Pricing
ESM3-open
- 1.4B parameter model
- Apache 2.0 license
- Available on Hugging Face/GitHub
- Local deployment support
Enterprise / API
- Full 98B parameter model
- AWS HealthOmics integration
- Priority support
- Custom fine-tuning capabilities
Pricing checked 5 months ago
Pricing guidance
- When the 1.4B model fails to generate viable structures for complex folds
- When you need to integrate with enterprise data security workflows on AWS
- When moving from pilot research to active drug candidate design
- AWS infrastructure costs are separate from EvolutionaryScale licensing
- The open-source version is significantly less capable than the flagship model
Premium enterprise positioning with a 'community-first' open-source hook.
Pros & Cons
Strengths
-
True generative capability
It doesn't just predict what a protein looks like; it creates new proteins from scratch to meet specific engineering goals.
-
Multimodal flexibility
The ability to prompt with structure and get sequence (or vice versa) makes it a versatile tool for different stages of the R&D pipeline.
-
Strong pedigree
Built by the team that created ESM-1 and ESM-2 at Meta, ensuring the underlying architecture is grounded in proven research.
-
Enterprise-ready deployment
Availability via AWS SageMaker and HealthOmics provides the security and scalability required by large pharma.
Weaknesses
-
High computational cost
Running the full 98B parameter model requires significant GPU resources, which may be prohibitive for smaller labs.
Affects: Early-stage startups and academic researchers
-
Steep learning curve
Requires deep expertise in both computational biology and machine learning to prompt and validate outputs effectively.
Affects: Traditional wet-lab biologists
-
Limited public benchmarking
While the 'esm-fluorescence' case study is impressive, independent large-scale benchmarks against other generative models are still emerging.
Affects: Decision-makers looking for validated ROI
Real User Sentiment
Highly positive and expectant within the scientific community, though tempered by the reality of wet-lab validation timelines.
Users tend to like
- The ability to generate novel proteins
- The multimodal 'tokenization' approach
- The team's track record with ESM-2
Users commonly complain about
- High barrier to entry for non-computational teams
- Lack of a user-friendly web interface for bench scientists
- Heavy reliance on the AWS ecosystem
Recurring tradeoffs
- Users trade simplicity for power; it is much harder to use than AlphaFold but far more capable for design.
Happiest users
Computational biology leads at well-funded biotech firms who need to move beyond simple structure prediction.
Often frustrated
Academic researchers with limited GPU budgets or wet-lab scientists without coding skills.
Use Cases
Enzyme Engineering
Designing new enzymes for industrial catalysis or plastic degradation.
Antibody Discovery
Generating novel antibody sequences that bind to specific viral epitopes.
Protein Scaffolding
Creating structural frameworks to support specific functional motifs.
Therapeutic Design
Developing proteins with specific binding affinities for drug targets.
Synthetic Biology
Programming entirely new biological functions into cellular systems.
Frequently Asked Questions
How does ESM3 compare to AlphaFold 3?
AlphaFold 3 is primarily a predictive model that excels at determining the structure of proteins and their interactions. ESM3 is a generative model designed to 'write' new protein sequences from scratch based on functional prompts. If you have a sequence and want the structure, use AlphaFold; if you have a function and want a new sequence, use ESM3.
Is there a free version of EvolutionaryScale?
Yes, EvolutionaryScale has released ESM3-open, a 1.4B parameter version of their model under the Apache 2.0 license. It is available on Hugging Face and GitHub for non-commercial and research use, though it is less powerful than the 98B parameter flagship model.
What are the hardware requirements for running ESM3?
The open-source 1.4B model can run on high-end consumer GPUs (like an NVIDIA A100 or H100). However, the full 98B model requires massive distributed compute, which is why it is primarily offered as a managed service through AWS HealthOmics and SageMaker.
Can ESM3 design proteins with non-natural amino acids?
Currently, ESM3 is trained on the vast diversity of natural proteins found in the Earth's metagenome. While it can generate novel combinations of natural amino acids, it is not natively designed for non-canonical amino acids without specific fine-tuning or prompting strategies.
Does EvolutionaryScale offer a web-based GUI?
No, EvolutionaryScale is currently a developer and researcher-focused platform. Access is provided via API, Python libraries, and cloud integrations. It is not a 'point-and-click' tool for bench scientists.
What integrations does it support?
The primary integration is with the AWS ecosystem, specifically AWS HealthOmics and SageMaker. It also integrates with standard computational biology workflows via Python and PyTorch.
Why trust this page?
This evaluation combines product positioning, pricing analysis, traffic and market signals, and public user sentiment into a single decision-support page. Content is generated editorially — not copied from the vendor's website.
Funding & Company
Founded
2023
Stage
Seed
Total Raised
$142M
Latest Round
Seed (Jun 2024)
Notable Investors
EvolutionaryScale has secured a substantial $142 million in a single Seed round in mid-2024. This significant early-stage investment from prominent tech investors and major cloud providers indicates strong confidence in its mission to apply large-scale AI to biological design and provides a long operational runway.
Market Signals & Traffic
Estimated visits, global rank, geography, traffic sources, monthly visit trends, and organic search keywords (Similarweb)—on a dedicated page built for depth and search.
- Estimated visits
- 0
- Global rank
- —
- Snapshot
- May 2026
- Traffic trend
- —
Similar Tools
Phind
AI Assistant, Developer Tools
AI-powered search engine for developers, providing instant answers and code snippets.
Fashable
Design, E-commerce, Content Creation
Generative design platform for the fashion and retail industry
Agenta
Developer Tools, Automation & Agents
Open-source platform for building, evaluating, and deploying LLM applications.
Replit
Developer Tools, AI Assistant
An AI-powered platform for building and deploying software applications directly from a browser.
Replicate
Developer Tools, Content Creation, AI Assistant
Run and deploy open-source AI models via a cloud API.
Smartling
Automation, Workflow, Content Creation
Enterprise translation management platform for global content localization.